This is an old revision of this page, as edited by VK35 (talk | contribs) at 20:00, 3 July 2007 (not FDA approved yet). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:00, 3 July 2007 by VK35 (talk | contribs) (not FDA approved yet)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Satraplatin is a platinum compound that is currently under investigation for the treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
The drug is taken by mouth. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPCbiotech under the name Spera.
The drug has also been used in the treatment of lung and ovarian cancers. The mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing.
References
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |